Recently, researchers looked at the frequency, phenotypic, and functional properties of CD4+T cells and CD8+ T cells in TB patients during anti-TB treatment and found inconsistent findings, with some reporting increases, decreases, and no change when compared to active TB patients before starting anti-TB drugs [15, 16]. This evidence concerns the gene CD8A and tuberculosis.